483 Response Vertex Pharmaceuticals Sep 2016

Vioela Caze FDA, Sean Marcsisin FDA, Edmund Mrak FDA, Kenneth Williams FDA$119.00 - Available Now

FDA investigators audited the Vertex Pharmaceuticals - Boston, MA, United States facility and issued inspectional observation (via FDA 483) on 21 Sep 2016.

Product details

  • Category:
  • Inspection end: 21 Sep 2016
  • Location: Boston, United States
  • FEI: 1000513211
Add To Cart